These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 23421330)
1. Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy. Knorr DA; Bock A; Brentjens RJ; Kaufman DS Stem Cells Dev; 2013 Jul; 22(13):1861-9. PubMed ID: 23421330 [TBL] [Abstract][Full Text] [Related]
2. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells. Zhu H; Kaufman DS Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935 [TBL] [Abstract][Full Text] [Related]
3. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Woll PS; Grzywacz B; Tian X; Marcus RK; Knorr DA; Verneris MR; Kaufman DS Blood; 2009 Jun; 113(24):6094-101. PubMed ID: 19365083 [TBL] [Abstract][Full Text] [Related]
5. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Knorr DA; Ni Z; Hermanson D; Hexum MK; Bendzick L; Cooper LJ; Lee DA; Kaufman DS Stem Cells Transl Med; 2013 Apr; 2(4):274-83. PubMed ID: 23515118 [TBL] [Abstract][Full Text] [Related]
6. Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs). Bock AM; Knorr D; Kaufman DS J Vis Exp; 2013 Apr; (74):e50337. PubMed ID: 23644738 [TBL] [Abstract][Full Text] [Related]
7. Development of innate immune cells from human pluripotent stem cells. Bernareggi D; Pouyanfard S; Kaufman DS Exp Hematol; 2019 Mar; 71():13-23. PubMed ID: 30611869 [TBL] [Abstract][Full Text] [Related]
8. Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo. Ni Z; Knorr DA; Bendzick L; Allred J; Kaufman DS Stem Cells; 2014 Apr; 32(4):1021-31. PubMed ID: 24307574 [TBL] [Abstract][Full Text] [Related]
9. iPSC-Derived Natural Killer Cells for Cancer Immunotherapy. Karagiannis P; Kim SI Mol Cells; 2021 Aug; 44(8):541-548. PubMed ID: 34373366 [TBL] [Abstract][Full Text] [Related]
10. The HOXB4 homeoprotein promotes the ex vivo enrichment of functional human embryonic stem cell-derived NK cells. Larbi A; Gombert JM; Auvray C; l'Homme B; Magniez A; Féraud O; Coulombel L; Chapel A; Mitjavila-Garcia MT; Turhan AG; Haddad R; Bennaceur-Griscelli A PLoS One; 2012; 7(6):e39514. PubMed ID: 22761810 [TBL] [Abstract][Full Text] [Related]
11. Pluripotent stem cell-derived natural killer cells for cancer therapy. Knorr DA; Kaufman DS Transl Res; 2010 Sep; 156(3):147-54. PubMed ID: 20801411 [TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Ni Z; Knorr DA; Clouser CL; Hexum MK; Southern P; Mansky LM; Park IH; Kaufman DS J Virol; 2011 Jan; 85(1):43-50. PubMed ID: 20962093 [TBL] [Abstract][Full Text] [Related]
13. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy. Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160 [TBL] [Abstract][Full Text] [Related]
14. The rise of human stem cell-derived natural killer cells for cancer immunotherapy. Wang K; Han Y; Cho WC; Zhu H Expert Opin Biol Ther; 2019 Feb; 19(2):141-148. PubMed ID: 30583701 [TBL] [Abstract][Full Text] [Related]
15. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. Woll PS; Martin CH; Miller JS; Kaufman DS J Immunol; 2005 Oct; 175(8):5095-103. PubMed ID: 16210613 [TBL] [Abstract][Full Text] [Related]
16. Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cells. de Rham C; Villard J Methods Mol Biol; 2013; 1029():65-75. PubMed ID: 23756942 [TBL] [Abstract][Full Text] [Related]
18. Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy. Zhu H; Lai YS; Li Y; Blum RH; Kaufman DS Stem Cells; 2018 Feb; 36(2):134-145. PubMed ID: 29235195 [TBL] [Abstract][Full Text] [Related]
19. Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. Preynat-Seauve O; de Rham C; Tirefort D; Ferrari-Lacraz S; Krause KH; Villard J J Cell Mol Med; 2009 Sep; 13(9B):3556-69. PubMed ID: 19320778 [TBL] [Abstract][Full Text] [Related]
20. Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes. Frenzel LP; Abdullah Z; Kriegeskorte AK; Dieterich R; Lange N; Busch DH; Krönke M; Utermöhlen O; Hescheler J; Sarić T Stem Cells; 2009 Feb; 27(2):307-16. PubMed ID: 18988711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]